Podoplanin is expressed on various tumor cells, including squamous cell carcinomas (SCCs), glioblastoma, osteosarcoma, bladder carcinoma, mesothelioma, and seminoma [32, 49–53], and its expression correlates with poor prognosis in brain and lung tumors [54–56]. Here, PDPN is linked to neoplasm.